ICON CEO and CFO to present at Jefferies November 17
ICON says event changes and available live-webcast links will be posted on its website; a conference-call replay will be available approximately one hour after the call ends.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
ICON plc announced that CEO Barry Balfe and CFO Nigel Clerkin will present at the Jefferies Global Healthcare Conference on November 17, 2026, at 12:30 p.m. GMT. Balfe will also participate in the 9th Annual Evercore Healthcare Conference on December 1, 2026, at 1:20 p.m. ET.
ICON employed approximately 40,250 people in 98 locations across 55 countries as of September 30, 2026. Event changes and live-webcast links, where available, will be posted on ICON’s investor website; a webcast replay will be available approximately one hour after the call concludes.
Key Figures
Jefferies presentation: November 17, 2026, 12:30 p.m. GMT
Evercore participation: December 1, 2026, 1:20 p.m. ET
Employees: Approximately 40,250 employees
+2 more
5 metrics
Jefferies presentation
November 17, 2026, 12:30 p.m. GMT
Jefferies Global Healthcare Conference
Evercore participation
December 1, 2026, 1:20 p.m. ET
9th Annual Evercore Healthcare Conference
Employees
Approximately 40,250 employees
As of September 30, 2026
Locations
98 locations
As of September 30, 2026
Countries
55 countries
As of September 30, 2026
Key Terms
clinical research organization, clinical development, post-marketing solutions
3 terms
clinical research organization technical
"a world-leading clinical research organization"
A clinical research organization (CRO) is a company that manages and runs human studies for medicines, medical devices and diagnostics on behalf of developers and sponsors. Think of a CRO as an outsourced project manager and contractor for testing — they recruit patients, collect data, handle regulatory paperwork and keep studies on schedule. Investors watch CROs because their quality and capacity affect development speed, cost and regulatory risk, which in turn influence when and whether products reach the market.
clinical development technical
"clinical development, commercialization and post-marketing solutions"
Clinical development is the process of testing a medical treatment in people to prove it is safe and works, moving from small early safety checks to larger trials that measure benefit and side effects. For investors it matters because each successful step reduces uncertainty and brings a product closer to regulatory approval and sales—like moving a prototype through road tests before mass production—while failures or delays can dramatically cut expected value.
post-marketing solutions technical
"commercialization and post-marketing solutions"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is ICON (ICLR) presenting at the Jefferies Global Healthcare Conference?
Barry Balfe, CEO of ICON, and Nigel Clerkin, CFO of ICON, will present on November 17, 2026, at 12:30 p.m. GMT.
When will ICON (ICLR) participate in the Evercore Healthcare Conference?
Barry Balfe, CEO of ICON, will participate in the 9th Annual Evercore Healthcare Conference on December 1, 2026, at 1:20 p.m. ET.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2026
Commission File Number: 333-08704
ICON plc
(Translation of registrant's name into English)
South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Ireland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
| Exhibit List | |||||
| Exhibit | Description | ||||
99.1 | ICON to Participate at Upcoming Investor Conferences | ||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ICON plc | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Date: November 10, 2026 | By: | /s/ Nigel Clerkin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name: | Nigel Clerkin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Title: | Chief Financial Officer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exhibit 99.1
ICON to Participate at Upcoming Investor Conferences
Dublin, Ireland, November 10, 2026 – ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that Mr. Barry Balfe, CEO of ICON plc, and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026 at 12:30pm GMT and Mr. Barry Balfe, CEO of ICON plc, will participate at the 9th Annual Evercore Healthcare Conference on Tuesday, December 1, 2026 at 1:20pm ET.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “Events”. A webcast replay of the conference call will be available approximately one hour following the conclusion of the call.
About ICON plc
ICON plc is a world-leading clinical research organization. Offering deep operational and medical expertise we accelerate innovation, driving emerging therapies forward to improve patient outcomes. From molecule to medicine, we deliver integrated consulting, clinical development, commercialization and post-marketing solutions to pharmaceutical, biotechnology, medical device, government and public health organizations worldwide. With headquarters in Dublin, Ireland, ICON employed approximately 40,250 employees in 98 locations in 55 countries as at September 30, 2026. For further information about ICON, visit: www.iconplc.com.
Source: ICON plc
Contact: Kate Haven Vice President Investor Relations +1888 381 7923
ICON/ICLR-G